Methyl Alcohol

Methyl Alcohol

SCHEMBL909941

CO.O=C(O)C(=O)C1CCCCC1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.65
CES1 P23141 1/20 0.65
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TSHR P16473 2/20 0.41
ALDH1A1 P00352 2/20 0.41
RECQL P46063 1/20 0.40
HSD11B1 P28845 4/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.36
EPHX1 P07099 1/20 0.35
LMNA P02545 1/20 0.35
SRD5A2 P31213 1/20 0.35
HAO1 Q9UJM8 1/20 0.35
HSD11B2 P80365 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2650157 0.95 CES2 (0.72) CES2CES1HDAC8HDAC6TSHR
SCHEMBL18199938 0.95 CES2 (0.72) CES2CES1HDAC8HDAC6TSHR
SCHEMBL6159646 0.95 CES2 (0.72) CES2CES1HDAC8HDAC6TSHR
Water SCHEMBL27570807 0.92 CES2 (0.68) CES2CES1HDAC8HDAC6TSHR
SCHEMBL873570 0.92 CES2 (0.67) CES2CES1HDAC8HDAC6TSHR
Benzene SCHEMBL27623531 0.90 CES2 (0.65) CES2CES1HDAC8HDAC6TSHR
SCHEMBL25248339 0.89 CES2 (0.63) CES2CES1HDAC8HDAC6TSHR
SCHEMBL11305314 0.89 CES2 (0.63) CES2CES1HDAC8HDAC6TSHR
Water SCHEMBL27559365 0.89 CES2 (0.63) CES2CES1HDAC8HDAC6TSHR
SCHEMBL873874 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487602-B2 Furan based resin, process for the preparation thereof, and use of the compound DSM IP ASSETS B.V. (NL) 2016-11-08 US claimed
US-20130109822-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP ASSETS B.V. (NL) 2013-05-02 US claimed
US-20110306735-A1 PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF DSM IP ASSETS B.V. (NL) 2011-12-15 US claimed
US-20110021740-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP ASSETS B.V. (NL) 2011-01-27 US claimed
EP-2222656-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP Assets B.V. (NL) 2010-09-01 EP claimed
US-20090203851-A1 Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof DSM IP ASSETS B.V. (NL) 2009-08-13 US claimed
WO-2009077587-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP ASSETS B.V. (NL) 2009-06-25 WO claimed
EP-2024317-A2 PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF DSMIP Assets B.V. (NL) 2009-02-18 EP claimed
WO-2007140941-A2 PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF DSM IP ASSETS B.V. (NL) 2007-12-13 WO claimed
US-9487602-B2 Furan based resin, process for the preparation thereof, and use of the compound DSM IP ASSETS B.V. (NL) 2016-11-08 US disclosed
US-20130109822-A1 FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP ASSETS B.V. (NL) 2013-05-02 US disclosed
US-20110306735-A1 PROCESS FOR THE PREPARATION OF A HYDROXY-AROMATIC RESIN; HYDROXY-AROMATIC RESIN, AND MODIFICATION THEREOF DSM IP ASSETS B.V. (NL) 2011-12-15 US disclosed
US-20110112260-A1 COMPOSITION COMPRISING A BLEND OF RESINS DSM IP ASSETS B.V. (NL) 2011-05-12 US disclosed
US-20110086988-A1 COMPOSITION COMPRISING POLYOLS EVONIK DEGUSSA GMBH (DE) 2011-04-14 US disclosed
WO-2006059903-A1 HYDROXY-AROMATIC COMPOUND, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND DSM IP ASSETS B.V. (NL) 2006-06-08 WO disclosed
EP-1633472-A1 ENCAPSULATED MATERIALS DSM IP Assets B.V. (NL) 2006-03-15 EP disclosed
US-20050176916-A1 Nitrogen-containing compound, the preparation thereof and application in amino-aldehyde resins DSM I.P. ASSETS B.V. (NL) 2005-08-11 US disclosed
EP-1507770-A2 NITROGEN-CONTAINING COMPOUND, THE PREPARATION THEREOF AND APPLICATION IN AMINO-ALDEHYDE RESINS DSM IP Assets B.V. (NL) 2005-02-23 EP disclosed
WO-2004110614-A1 ENCAPSULATED MATERIALS DSM IP ASSETS B.V. (NL) 2004-12-23 WO disclosed
WO-2003101973-A2 NITROGEN-CONTAINING COMPOUND, THE PREPARATION THEREOF AND APPLICATION IN AMINO-ALDEHYDE RESINS DSM IP ASSETS B.V. (NL) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203851-A1 Process for the Preparation of a Hydroxy-Aromatic Resin: Hydroxy-Aromatic Resin, and Modification Thereof HRH3, HRH1, C9 CES2 973/4885CES1 2109/4885HDAC8 3184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.